988 results
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
and Management Initiative ... Medications: Agent, Initiation
Factors to be considered in deciding to initiate treatment empirically for active tuberculosis (TB) (prior to
in deciding to initiate ... #tuberculosis #initiation ... #management #IDSA
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... condition #IDSA
IDSA Recommended antimicrobial regimens for treatment of patients with Lyme disease.

#Management #InfectiousDiseases #Antibiotics #LymeDisease #Treatment #Regimens
IDSA Recommended ... Treatment #Regimens #IDSA
Tumor lysis syndrome (TLS) - Pathophysiology:
→ Massive tumor cell lysis
→ Release of large amounts of K+,
syndrome (TLS) - Pathophysiology ... Usually after initiating ... syndrome #TLS #Pathophysiology
IDSA - Antimicrobial Therapy for Staphylococcal and Streptococcal Skin and Soft Tissue Infections
 • Impetigo (Staphylococcus
IDSA - Antimicrobial ... management #treatment #idsa
Metformin in Diabetic Kidney Disease
Immediate release:
 • Initial 500 mg or 850 mg once daily
 •
dose eGFR 30-44: Initiate ... metformin; do not initiate ... management #kdigo #initiation
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... #pharmacology #IDSA
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... #medications #IDSA
IDSA Algorithm for Management of Acute Uncomplicated Cystitis
Approach to choosing an optimal antimicrobial agent for empirical
IDSA Algorithm for ... Uncomplicated #Cystitis #IDSA